Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 11 studies | 36% ± 24% | |
oligodendrocyte precursor cell | 9 studies | 26% ± 12% | |
renal alpha-intercalated cell | 6 studies | 41% ± 15% | |
GABAergic neuron | 6 studies | 45% ± 22% | |
endothelial cell | 5 studies | 25% ± 8% | |
epithelial cell | 5 studies | 28% ± 14% | |
cardiac muscle cell | 5 studies | 26% ± 7% | |
astrocyte | 5 studies | 30% ± 12% | |
neuron | 4 studies | 26% ± 5% | |
adipocyte | 4 studies | 25% ± 6% | |
interneuron | 4 studies | 49% ± 21% | |
oligodendrocyte | 4 studies | 26% ± 7% | |
ionocyte | 3 studies | 23% ± 5% | |
GABAergic interneuron | 3 studies | 24% ± 2% | |
transit amplifying cell | 3 studies | 36% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 4681.86 | 2626 / 2642 | 100% | 60.79 | 704 / 705 |
prostate | 99% | 2277.04 | 243 / 245 | 99% | 54.62 | 499 / 502 |
thymus | 99% | 2105.62 | 646 / 653 | 98% | 51.66 | 593 / 605 |
breast | 100% | 2753.89 | 459 / 459 | 95% | 33.47 | 1065 / 1118 |
skin | 100% | 3258.98 | 1807 / 1809 | 93% | 42.34 | 440 / 472 |
uterus | 99% | 2305.49 | 169 / 170 | 93% | 42.64 | 429 / 459 |
esophagus | 100% | 3433.61 | 1443 / 1445 | 90% | 29.32 | 164 / 183 |
kidney | 98% | 2319.26 | 87 / 89 | 91% | 58.28 | 823 / 901 |
adrenal gland | 93% | 1375.26 | 239 / 258 | 90% | 30.46 | 207 / 230 |
lung | 91% | 1254.17 | 528 / 578 | 90% | 29.24 | 1044 / 1155 |
intestine | 99% | 2478.93 | 956 / 966 | 83% | 21.96 | 436 / 527 |
ovary | 99% | 1602.09 | 179 / 180 | 82% | 17.56 | 352 / 430 |
stomach | 99% | 2709.18 | 357 / 359 | 77% | 20.14 | 220 / 286 |
bladder | 95% | 2073.86 | 20 / 21 | 70% | 20.46 | 354 / 504 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.67 | 45 / 45 |
blood vessel | 100% | 3035.78 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 3183.85 | 1203 / 1204 | 0% | 0 | 0 / 0 |
spleen | 98% | 1232.65 | 237 / 241 | 0% | 0 | 0 / 0 |
pancreas | 6% | 47.59 | 19 / 328 | 91% | 21.03 | 162 / 178 |
lymph node | 0% | 0 | 0 / 0 | 97% | 43.26 | 28 / 29 |
heart | 95% | 8386.08 | 822 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 2489.49 | 744 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 33.41 | 72 / 80 |
peripheral blood | 28% | 1560.79 | 263 / 929 | 0% | 0 | 0 / 0 |
liver | 0% | 4.03 | 1 / 226 | 17% | 3.72 | 67 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042182 | Biological process | ketone catabolic process |
GO_0046952 | Biological process | ketone body catabolic process |
GO_0046950 | Biological process | cellular ketone body metabolic process |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0008260 | Molecular function | succinyl-CoA:3-oxo-acid CoA-transferase activity |
Gene name | OXCT1 |
Protein name | Succinyl-CoA:3-ketoacid-coenzyme A transferase (EC 2.8.3.5) 3-oxoacid CoA-transferase 1 Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (SCOT) (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase) Succinyl-CoA:3-ketoacid CoA transferase |
Synonyms | hCG_37537 SCOT OXCT |
Description | FUNCTION: Key enzyme for ketone body catabolism. Catalyzes the first, rate-limiting step of ketone body utilization in extrahepatic tissues, by transferring coenzyme A (CoA) from a donor thiolester species (succinyl-CoA) to an acceptor carboxylate (acetoacetate), and produces acetoacetyl-CoA. Acetoacetyl-CoA is further metabolized by acetoacetyl-CoA thiolase into two acetyl-CoA molecules which enter the citric acid cycle for energy production . Forms a dimeric enzyme where both of the subunits are able to form enzyme-CoA thiolester intermediates, but only one subunit is competent to transfer the CoA moiety to the acceptor carboxylate (3-oxo acid) and produce a new acyl-CoA. Formation of the enzyme-CoA intermediate proceeds via an unstable anhydride species formed between the carboxylate groups of the enzyme and substrate (By similarity). . FUNCTION: Key enzyme for ketone body catabolism. Transfers the CoA moiety from succinate to acetoacetate. Formation of the enzyme-CoA intermediate proceeds via an unstable anhydride species formed between the carboxylate groups of the enzyme and substrate. . |
Accessions | ENST00000509987.1 E9PDW2 A1E286 ENST00000510634.5 [P55809-2] ENST00000196371.10 [P55809-1] ENST00000512084.5 [P55809-2] P55809 A0A024R040 |